We're aware of a cyber security incident affecting the electronic prescriptions provider MediSecure. The eRX Script Exchange (eRX) and the National Prescription Delivery Service (NPDS) continue to operate as usual and have not been impacted. Find out more and read our statement here.

Submission to the Therapeutic Goods Administration on the Proposed amendments to the Poisons Standard

Last updated 3 June 2022


Date: 2 June 2022

The RACGP opposes both the down scheduling of Budesonide from Schedule 4 to Schedule 3, and changes to amendments to the Schedule 4 entry for hydroxypinacolone retinoate. Our response highlights the GP’s role and why it is inappropriate for pharmacists to prescribe these medications.